Table 2. Effect of MB/MV Analogues (1–5) on the Cellular Viability of Primary FRDA Fibroblasts against Erastin-Induced Ferroptotic Cell Deatha.
Compound | Erastin challenge cell survival EC50 (nM) |
---|---|
MB | 43 ± 3 |
MV | 27 ± 3 |
1a | 39 ± 3 |
1b | 15 ± 2 |
2a | 37 ± 3 |
2b | 11 ± 1 |
3a | 29 ± 3 |
3b | 10 ± 1 |
4a | 35 ± 1 |
4b | 15 ± 1 |
5a | 55 ± 6 |
5b | 22 ± 2 |
Lip-1 | 22 ± 4 |
Fer-1 | 33 ± 4 |
α-TOH | >500 |
The calculated EC50 values were determined graphically from the dose–response curves using the nonlinear regression curve fit analysis model.